Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PED-COVID: Seroprevalence and Antibody Profiling Against SARS-CoV2 in Children and Parents
NCT04355533Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2020
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Open-label trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Seroconversion against SARS-CoV2 in children. Started Jul 2020; status: completed.
Beyond the preview
Go deeper on NCT04355533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355533.